Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M45,817Revenue (TTM) $M101,412Net Margin (%)2.6Altman Z-Score3.1
Enterprise Value $M60,484EPS (TTM) $4.0Operating Margin %4.5Piotroski F-Score8
P/E(ttm)18.0Beneish M-Score-2.6Pre-tax Margin (%)4.0Higher ROA y-yY
Price/Book3.010-y EBITDA Growth Rate %22.5Quick Ratio0.5Cash flow > EarningsY
Price/Sales0.55-y EBITDA Growth Rate %17.1Current Ratio0.6Lower Leverage y-yY
Price/Free Cash Flow11.0y-y EBITDA Growth Rate %21.6ROA % (ttm)5.2Higher Current Ratio y-yN
Dividend Yield %--PEG1.1ROE % (ttm)16.8Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M630ROIC % (ttm)9.9Gross Margin Increase y-yY

Gurus Latest Trades with ESRX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ESRXArnold Van Den Berg 2016-06-30 Buy 1.24%$67.24 - $76.95
($73.45)
$ 72.70-1%New holding97,615
ESRXBarrow, Hanley, Mewhinney & Strauss 2016-06-30 Add0.56%$67.24 - $76.95
($73.45)
$ 72.70-1%Add 49.88%14,646,371
ESRXDavid Dreman 2016-06-30 Add0.54%$67.24 - $76.95
($73.45)
$ 72.70-1%Add 74.94%27,122
ESRXHOTCHKIS & WILEY 2016-06-30 Reduce-0.23%$67.24 - $76.95
($73.45)
$ 72.70-1%Reduce -50.14%775,261
ESRXJoel Greenblatt 2016-06-30 Reduce-0.15%$67.24 - $76.95
($73.45)
$ 72.70-1%Reduce -16.87%962,979
ESRXChris Davis 2016-06-30 Reduce-0.06%$67.24 - $76.95
($73.45)
$ 72.70-1%Reduce -3.64%4,955,717
ESRXLeucadia National 2016-06-30 Sold Out -0.04%$67.24 - $76.95
($73.45)
$ 72.70-1%Sold Out0
ESRXCharles Brandes 2016-06-30 Reduce-0.04%$67.24 - $76.95
($73.45)
$ 72.70-1%Reduce -1.93%2,126,580
ESRXDodge & Cox 2016-06-30 Reduce-0.03%$67.24 - $76.95
($73.45)
$ 72.70-1%Reduce -1.71%21,691,413
ESRXKeeley Asset Management Corp 2016-06-30 Sold Out -0.03%$67.24 - $76.95
($73.45)
$ 72.70-1%Sold Out0
ESRXWallace Weitz 2016-06-30 Reduce-0.03%$67.24 - $76.95
($73.45)
$ 72.70-1%Reduce -1.06%1,046,771
ESRXMario Gabelli 2016-06-30 Reduce-0.01%$67.24 - $76.95
($73.45)
$ 72.70-1%Reduce -10.12%97,743
ESRXGeorge Soros 2016-06-30 Sold Out -0.01%$67.24 - $76.95
($73.45)
$ 72.70-1%Sold Out0
ESRXKen Fisher 2016-06-30 Reduce$67.24 - $76.95
($73.45)
$ 72.70-1%Reduce -6.27%352,068
ESRXSteve Mandel 2016-03-31 Sold Out -1.19%$66.37 - $87.6
($72.1)
$ 72.701%Sold Out0
ESRXBarrow, Hanley, Mewhinney & Strauss 2016-03-31 Buy 1.03%$66.37 - $87.6
($72.1)
$ 72.701%New holding9,772,328
ESRXRobert Olstein 2016-03-31 Add0.75%$66.37 - $87.6
($72.1)
$ 72.701%Add 167.55%131,100
ESRXJoel Greenblatt 2016-03-31 Add0.62%$66.37 - $87.6
($72.1)
$ 72.701%Add 224.25%1,158,428
ESRXDodge & Cox 2016-03-31 Reduce-0.3%$66.37 - $87.6
($72.1)
$ 72.701%Reduce -13.52%22,069,813
ESRXChris Davis 2016-03-31 Reduce-0.14%$66.37 - $87.6
($72.1)
$ 72.701%Reduce -7.03%5,142,979
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ESRX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ESRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Neville EverettSenior VP, Supply Chain 2016-05-10Sell800$74.11-2.05view
MAC MAHON THOMAS PDirector 2016-04-29Sell5,482$73.93-1.81view
McGinnis Christopher AVP, Controller & Ch. Acct. Off 2016-03-10Sell579$68.565.88view
Anderson Phyllis S.Sr. VP & Ch. Marketing Officer 2016-03-07Sell614$71.142.04view
Houston ChristineSenior VP, Operations 2016-03-01Sell8,721$71.551.45view
Neville EverettSenior VP, Supply Chain 2016-02-29Sell4,323$712.24view
Wimberly GarySr. VP & Ch. Information Off. 2015-06-09Sell1,644$87.14-16.7view
Wimberly GarySr. VP & Ch. Information Off. 2015-06-01Sell46,069$86.15-15.74view
STERNBERG SEYMOURDirector 2015-05-27Sell6,870$90.23-19.55view
MYERS WOODROW A JRDirector 2015-05-08Sell14,342$85.32-14.92view

Quarterly/Annual Reports about ESRX:

News about ESRX:

Articles On GuruFocus.com
Healthcare Growth Stocks in the S&P 500: Part 2 Aug 12 2016 
Healthcare Growth Stocks in the S&P 500: Part 2 Aug 12 2016 
Arnold Van Den Berg 2nd Quarter: Cuts Back on Gold Miners, Gets More Bullish on Oil Jul 25 2016 
Van Den Berg Made 6 New Buys in 2nd Quarter Jul 24 2016 
David Rolfe Comments on Express Scripts Jul 13 2016 
David Rolfe's Wedgewood Partners 2nd Quarter 2016 Client Letter Jul 12 2016 
David Rolfe Nearly Divests Stake in M&T Bank Jun 26 2016 
Brandes Investments Comments on Express Scripts Jun 15 2016 
Brandes Global Equity Fund 1st Quarter Commentary Jun 15 2016 
Express Scripts: Is This a Value Investing Opportunity or a Legal Quagmire? Jun 08 2016 

More From Other Websites
Why These Five Stocks Are Trending Today Aug 31 2016
Express Scripts' New Program to Lower Diabetes Care Costs Aug 31 2016
PBMs Quietly Gain Leverage As Drug Makers Stumble On Price Hikes Aug 31 2016
Express Scripts launches program to control diabetes costs Aug 31 2016
Express Scripts Launches Diabetes Care Value Program℠, Guaranteeing More Affordable,... Aug 30 2016
Express Scripts diabetes program aims to cap costs for customers Aug 30 2016
Express Scripts Launches Diabetes Care Value Program℠, Guaranteeing More Affordable,... Aug 30 2016
Large contract with Express Scripts keeps Alphapointe growing Aug 30 2016
Blog Coverage Walgreens Boots Alliance Partners with Prime Therapeutics for a Bigger Slice of the... Aug 30 2016
The Insurance Rip-Off At The Heart Of The EpiPen Scandal Aug 30 2016
Mylan launching cheaper, generic version of EpiPen Aug 29 2016
Healthcare's best bets following generic EpiPen Aug 29 2016
Mylan launching cheaper, generic version of EpiPen Aug 29 2016
Street Talk: BABA, ESRX & more Aug 26 2016
Pharmacy owner: There's a huge issue with PBMs Aug 26 2016
Pharmacy Benefit Managers Shouldn't Fret Initial Fallout from Mylan Fiasco Aug 26 2016
Express Scripts: Is EpiPen Reaction Overblown? Aug 26 2016
Express Scripts (ESRX) Stock Up, Jefferies: EpiPen Concerns 'Overdone' Aug 26 2016
EpiPen pricing under fire Aug 26 2016
5 Things You Must Know Before the Market Opens Friday Aug 26 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)